Patent details
EP3222278 Title: USE OF AZELNIDIPINE IN PREPARING MEDICINAL COMPOSITION FOR TREATING CANCERS
Basic Information
- Publication number:
- EP3222278
- PCT Application Number:
- CN2015092714
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP158527812
- PCT Publication Number:
- WO2016062275
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- USE OF AZELNIDIPINE IN PREPARING MEDICINAL COMPOSITION FOR TREATING CANCERS
- French Title of Invention:
- UTILISATION DE L'AZELNIDIPINE POUR LA PRÉPARATION D'UNE COMPOSITION PHARMACEUTIQUE INDIQUÉE POUR LE TRAITEMENT DU CANCER
- German Title of Invention:
- VERWENDUNG VON AZELNIDIPIN ZUR HERSTELLUNG EINER MEDIZINISCHEN ZUSAMMENSETZUNG ZUR BEHANDLUNG VON KREBS
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 21/06/2023
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 12/07/2023
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 14/06/2023
- Unitary Effect Registration Date:
- 12/07/2023
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 23/10/2015
- Grant date:
- 14/06/2023
- EP Publication Date:
- 27/09/2017
- PCT Publication Date:
- 28/04/2016
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 14/06/2023
- EP B1 Publication Date:
- 14/06/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 23/10/2035
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 07/06/2023
- Name:
- Launx Biomedical Co., Ltd.
- Address:
- 2F. No.1 Ln. 32 Ziqiang 1st Rd. Qianjin Dist., Kaohsiung City 801, Taiwan (TW)
Inventor
1
- Name:
- CHUANG, Show-Mei
- Address:
- Taiwan (TW)
2
- Name:
- HSIAO, Nai-Wan
- Address:
- Taiwan (TW)
3
- Name:
- CHEN, Chiu-Hung
- Address:
- Taiwan (TW)
4
- Name:
- WAY, Tzong-Der
- Address:
- Taiwan (TW)
Priority
- Priority Number:
- 201462068298 P
- Priority Date:
- 24/10/2014
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/4422; A61P 35/00; A61P 35/04;
Publication
European Patent Bulletin
1
- Issue number:
- 202324
- Publication date:
- 14/06/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202330
- Publication date:
- 26/07/2023
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202333
- Publication date:
- 16/08/2023
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|